Sanofi and Medtronic team up on diabetes drug-device combination

June 14, 2014 3:55 PM

7 0

Sanofi and Medtronic team up on diabetes drug-device combination

The announcement comes as Sanofi seeks to defend its No.2 spot in a global diabetes market worth over $40 billion, at a time when top-selling drug Lantus, the world's most prescribed insulin, is set to lose patent protection early next year.

Under the terms of a memorandum of understanding, Sanofi and Medtronic will initially cooperate on developing drug-device combinations and offering care management services for diabetes patients. Depending on the results, they will consider other areas for collaboration, the companies said in a stat...

Also read: EU fines 3 banks $520 million over market rigging

Read more

To category page

Loading...